Page last updated: 2024-11-01

nilvadipine and Kidney Diseases

nilvadipine has been researched along with Kidney Diseases in 2 studies

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research Excerpts

ExcerptRelevanceReference
"Nilvadipine appears to be an effective hypotensive agent at single daily doses of 8 mg."5.28Nilvadipine in hypertension with renal dysfunction. ( Albert, FW; Berger, HH, 1992)
"Nilvadipine appears to be an effective hypotensive agent at single daily doses of 8 mg."1.28Nilvadipine in hypertension with renal dysfunction. ( Albert, FW; Berger, HH, 1992)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mitamura, T1
Yamada, A1
Ishida, H1
Fujihira, S1
Ohara, K1
Noguchi, H1
Mine, Y1
Berger, HH1
Albert, FW1

Other Studies

2 other studies available for nilvadipine and Kidney Diseases

ArticleYear
Tacrolimus (FK506)-induced nephrotoxicity in spontaneous hypertensive rats.
    The Journal of toxicological sciences, 1994, Volume: 19, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterioles; Blood Urea Nitrogen; Creatinine; Hypertension; Ki

1994
Nilvadipine in hypertension with renal dysfunction.
    Journal of cardiovascular pharmacology, 1992, Volume: 20 Suppl 6

    Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Creatinine; Female; Heart Rate; H

1992